A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo

Breast cancer is the most common malignant cancer in women worldwide, especially in developing countries. Herceptin is a monoclonal antibody with an antitumor effect in HER2-positive breast cancer. However, the large molecular weight of Herceptin limited its employment. In this study, we constructed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Cheng, Xiao, Li, Lin, Zhang, Rumeng, Zhu, Yong, Wu, Zhengsheng, Ding, Keshuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149955/
https://www.ncbi.nlm.nih.gov/pubmed/34055637
http://dx.doi.org/10.3389/fonc.2021.669393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149955/
https://www.ncbi.nlm.nih.gov/pubmed/34055637
http://dx.doi.org/10.3389/fonc.2021.669393

Ejemplares similares